Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
litigation
Fierce Biotech
FibroGen pays SEC $1.2M over claims of 'reverse engineered' data
FibroGen has agreed to pay $1.25 million to the SEC to settle allegations that its former chief medical officer manipulated data for the anemia drug.
James Waldron
Sep 11, 2025 10:41am
University of Michigan seeks damages over AZ's FluMist sales
Aug 29, 2025 10:15am
Amgen's ChemoCentryx prevails in investor lawsuit
Aug 19, 2025 10:13am
Sun Pharma beats Incyte in appeals, teeing up US alopecia launch
Apr 10, 2025 10:00am
Jazz Pharma settles Xyrem antitrust claims for $145M
Apr 10, 2025 8:50am
Troubled Mallinckrodt, Endo telegraph $6.7B merger plans
Mar 13, 2025 10:18am
